Streptococcus pneumoniae serotype 6B capsular polysaccharide

The **Streptococcus pneumoniae serotype 6B capsular polysaccharide** is a high-molecular-weight carbohydrate polymer that forms the outermost layer encapsulating S. pneumoniae bacteria of this specific serotype. It is composed of repeating oligosaccharide units whose precise structure defines the immunological identity ("serotyping") and biological properties unique to type 6B strains. The capsule serves as a major virulence factor by protecting bacteria from phagocytosis by host immune cells and modulating interactions with the host environment[7][8]. The chemical structure consists primarily of glucose, rhamnose, ribitol-phosphate residues arranged in a defined sequence; this structure is recognized specifically by anti-serogroup 6 antibodies and forms the basis for its inclusion in pneumococcal conjugate vaccines such as PCV13[2][3]. The presence or absence—and structural details—of this capsule are critical determinants for both pathogenicity and epidemiology within human populations. Targeting this molecule through vaccination induces an adaptive immune response that can prevent invasive pneumococcal disease caused by type 6B strains. The molecule itself is not an enzyme or receptor but rather a **surface-exposed bacterial carbohydrate polymer** classified functionally as an "other" molecular class—specifically as a virulence factor and vaccine antigen. No evidence suggests misspelling or incorrectness regarding this target name; it refers to a well-defined molecular entity central to both pathogenesis and prevention strategies against S. pneumoniae infection[2][3][7][8].

Other names

S. pneumoniae serotype 6B CPSPneumococcal serotype 6B capsuleSerotype 6B capsular polysaccharide

Induction of protective antibodies that promote opsonization and clearance by the immune system when used as a vaccine antigen